首頁 > 市場調查報告書 > 醫療設備

整形外科脊柱植入

市場調查報告書

商品編碼

1643330

MIS骶髂關節融合術的全球市場

MIS Sacroiliac Joint Fusion

出版日期: 2025年01月27日 | 出版商:

Global Industry Analysts, Inc. | 英文 467 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到2030年，MIS骶髂關節融合術的全球市場預計將達到17億美元

MIS 骶髂融合術的全球市場預計到 2024 年將達到 8.681 億美元，預計在 2024-2030 年分析期間將以 11.5% 的複合年成長率成長，並在 2030 年達到 17 億美元。植入是 MIS 骶髂關節融合術報告中分析的細分市場之一，複合年成長率為 12.5%，預計到分析期結束時將達到 13 億美元。在分析期間，MIS 骶髂關節融合術儀器和設備部門的複合年成長率預計為 8.6%。

美國市場預估價值2.365億美元，中國預期複合年成長率15.8%

2024年美國MIS骶髂關節融合術市場預計為2.365億美元。中國作為世界第二大經濟體，預計到 2030 年市場規模將達到 3.507 億美元，2024-2030 年分析期間複合年成長率為 15.8%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 8.3% 和 10.3%。在歐洲，德國的複合年成長率預計約為 9.1%。

全球 MIS 骶髂關節融合術市場 – 主要趨勢與促進因素總結

為什麼MIS骶髂融合術在醫療保健領域越來越受歡迎

微創骶髂關節（SI）融合術已成為治療因骶髂關節功能障礙而患有慢性下背痛的患者的變革性解決方案。隨著退化性髂關節炎、創傷和關節炎等疾病的治療變得越來越流行，對有效治療方案的需求也越來越大。與傳統手術方法不同，微創技術具有更快的恢復時間、更小的切口和更少的術後不適，越來越受到患者和醫療保健提供者的青睞。此外，世界人口老化加劇，更容易出現骶髂關節功能障礙，也是推動 MIS 手術採用的主要因素。此外，人們對早期診斷和治療骶髂關節問題的其他好處的認知不斷提高，導致對先進外科手術的需求激增，進一步推動了該市場的成長。

科技進步如何徹底改變 MIS 骶髂融合術？

醫療技術的進步處於 MIS 骶髂關節融合術市場快速成長的前沿。診斷影像和導航系統的創新顯著提高了手術精確度，降低了併發症的風險，並改善了患者的治療效果。鈦和生物活性材料等新型植入材料的開發提高了植入的耐用性和完整性，從而實現更好的恢復和長期結果。機器人輔助手術和電腦輔助規劃工具進一步簡化了手術程序，使外科醫生能夠以最小的侵入性獲得更高的精確度。此外，擴增實境(AR) 在手術規劃中的整合正在改變外科醫生可視化和處理複雜病例的方式。這些進步不僅提高了臨床效率，也增強了患者選擇 MIS 手術的信心，推動市場成長。

塑造市場軌跡的區域動態是什麼？

MIS 骶髂關節融合術市場受到多樣化的醫療基礎設施、經濟狀況和患者人口統計的影響，並且按地區擴張不均勻。由於高額醫療保健支出、既定的報銷框架以及先進醫療技術的可用性，北美在市場上佔據主導地位。在骶髂關節疾病盛行率上升和對微創手術日益偏好的推動下，歐洲正經歷穩定成長。另一方面，由於醫療保健投資增加、對骶髂關節功能障礙的認知提高以及人口迅速老化，亞太地區是一個快速成長的市場，潛力巨大。印度和中國等新興國家政府致力於擴大醫療保健覆蓋範圍，創造市場滲透機會。此外，由於醫療基礎設施的改善和醫療旅遊業的增加，MIS 技術逐漸在中東和非洲被採用。

MIS骶髂關節融合術市場成長的驅動力是什麼？

MIS 骶髂關節融合術市場的成長受到多種因素的推動，包括手術技術的進步和不斷變化的患者偏好。腰痛及相關疾病的盛行率不斷上升，尤其是在老年人和體力活躍的人群中，這增加了對有效、微創治療的需求。對醫療保健基礎設施和研發舉措的投資增加正在推動更有效率、更適合患者的手術器械和植入的開發。醫療保健專業人員對早期療育好處的認知不斷提高，導致這些程序的採用率提高。此外，已開發地區有利的報銷政策和新興市場專業外科手術的不斷增加也促進了市場的成長。這些因素共同賦予 MIS 骶髂關節融合術的巨大潛力，能夠有效率且有效地滿足不斷成長的醫療保健需求。

部分

產品（MIS骶髂關節融合術植入、MIS骶髂關節融合術器材和設備）；適應症（退化性骶髂關節炎適應症、創傷適應症、骶髂關節功能）；最終用途（醫院最終用途）；門診手術中心最終用途、其他最終用途）

受訪企業範例（44家知名企業）

Camber Spine Technologies, LLC
CoreLink Surgical
CornerLoc
Globus Medical, Inc.
Life Spine, Inc.
Medtronic Plc
Microspine PLC
Orthofix Medical Inc.
PainTEQ
SI-BONE, Inc.

The global market for MIS Sacroiliac Joint Fusion estimated at US$868.1 Million in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 11.5% over the analysis period 2024-2030. MIS Sacroiliac Joint Fusion Implants, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the MIS Sacroiliac Joint Fusion Instruments & Equipment segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$236.5 Million While China is Forecast to Grow at 15.8% CAGR

The MIS Sacroiliac Joint Fusion market in the U.S. is estimated at US$236.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$350.7 Million by the year 2030 trailing a CAGR of 15.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 10.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

Global MIS Sacroiliac Joint Fusion Market - Key Trends & Drivers Summarized

Why Is MIS Sacroiliac Joint Fusion Gaining Popularity in the Healthcare Sector?

Minimally invasive sacroiliac (SI) joint fusion has emerged as a transformative solution for patients suffering from chronic lower back pain caused by sacroiliac joint dysfunction. The growing prevalence of conditions such as degenerative sacroiliitis, trauma, and arthritis has amplified the demand for effective treatment options. Unlike traditional surgical approaches, minimally invasive techniques offer reduced recovery times, smaller incisions, and less post-operative discomfort, making them increasingly preferred by both patients and healthcare providers. The global rise in aging populations, who are more susceptible to SI joint dysfunction, is also a significant factor driving the adoption of MIS techniques. Additionally, the increasing awareness of the benefits of early diagnosis and treatment of sacroiliac joint issues has led to a surge in demand for advanced surgical procedures, further propelling the growth of this market.

How Are Technological Advancements Revolutionizing MIS Sacroiliac Joint Fusion?

Advances in medical technology are at the forefront of the rapid growth in the MIS sacroiliac joint fusion market. Innovations in imaging and navigation systems have significantly enhanced surgical precision, reducing the risk of complications and improving patient outcomes. The development of novel implant materials, such as titanium and bioactive substances, has improved the durability and integration of implants, fostering better recovery and long-term results. Robotic-assisted surgeries and computer-aided planning tools are further streamlining procedures, enabling surgeons to achieve higher accuracy with minimal invasiveness. Moreover, the integration of augmented reality (AR) in surgical planning is transforming how surgeons visualize and approach complex cases. These advancements not only improve clinical efficiency but also increase patient confidence in opting for MIS procedures, thus driving market growth.

What Are the Regional Dynamics Shaping the Market's Trajectory?

The market for MIS sacroiliac joint fusion is expanding unevenly across regions, shaped by diverse healthcare infrastructures, economic conditions, and patient demographics. North America dominates the market, driven by high healthcare spending, well-established reimbursement frameworks, and the availability of advanced medical technologies. Europe is witnessing steady growth, fueled by the rising incidence of sacroiliac joint disorders and a growing preference for minimally invasive procedures. Meanwhile, the Asia-Pacific region represents a burgeoning market with immense potential due to increasing healthcare investments, rising awareness about SI joint dysfunctions, and a rapidly aging population. Governments in emerging economies like India and China are focusing on expanding healthcare access, creating opportunities for market penetration. Additionally, the Middle East and Africa are gradually adopting MIS techniques, spurred by improvements in healthcare infrastructure and increased medical tourism.

What Is Driving Growth in the MIS Sacroiliac Joint Fusion Market?

The growth in the MIS sacroiliac joint fusion market is driven by several factors, including advancements in surgical technology and evolving patient preferences. The rising prevalence of lower back pain and related conditions, particularly among older adults and physically active individuals, has created a robust demand for effective and minimally invasive treatments. Increasing investments in healthcare infrastructure and R&D initiatives have facilitated the development of more efficient and patient-friendly surgical tools and implants. The growing awareness among healthcare professionals about the benefits of early intervention has led to higher adoption rates of these procedures. Furthermore, favorable reimbursement policies in developed regions and the expanding availability of specialized surgical expertise in emerging markets are contributing to market growth. Together, these drivers underscore the strong potential for MIS sacroiliac joint fusion to address an ever-growing healthcare need efficiently and effectively.

SCOPE OF STUDY:

The report analyzes the MIS Sacroiliac Joint Fusion market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (MIS Sacroiliac Joint Fusion Implants, MIS Sacroiliac Joint Fusion Instruments & Equipment); Approach (Dorsal Approach, Anterior Approach); Indication (Degenerative Sacroiliitis Indication, Trauma Indication, Sacroiliac Joint Dysfunction Indication); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

Camber Spine Technologies, LLC
CoreLink Surgical
CornerLoc
Globus Medical, Inc.
Life Spine, Inc.
Medtronic Plc
Microspine PLC
Orthofix Medical Inc.
PainTEQ
SI-BONE, Inc.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Economic Frontiers: Trends, Trials & Transformations
- MIS Sacroiliac Joint Fusion - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Prevalence of Lower Back Pain Drives Demand for MIS Sacroiliac Joint Fusion
- Advancements in Minimally Invasive Surgical Techniques Enhance Market Adoption
- Increasing Focus on Patient Outcomes Fuels Demand for MIS Procedures
- Growth in Aging Population Propels Sacroiliac Joint Fusion Market Expansion
- Role of MIS Techniques in Reducing Postoperative Recovery Times Boosts Adoption
- Rising Use of Navigation and Robotics in MIS Sacroiliac Joint Fusion Expands Opportunities
- Improved Awareness Among Physicians Drives Adoption of MIS Sacroiliac Procedures
- Technological Innovations in Implant Designs Enhance Market Potential
- Growing Focus on Ambulatory Surgical Centers Fuels Demand for MIS Procedures
- Increasing Availability of Reimbursement Policies Propels Market Growth
- Demand for Pain Management Solutions Drives Adoption of MIS Techniques
- Rising Investments in R&D for Advanced MIS Sacroiliac Joint Fusion Products
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World MIS Sacroiliac Joint Fusion Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for MIS Sacroiliac Joint Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for MIS Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for MIS Sacroiliac Joint Fusion Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for MIS Sacroiliac Joint Fusion Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion Instruments & Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for MIS Sacroiliac Joint Fusion Instruments & Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for MIS Sacroiliac Joint Fusion Instruments & Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Dorsal Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Dorsal Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 22: World 15-Year Perspective for Dorsal Approach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Anterior Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Anterior Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 25: World 15-Year Perspective for Anterior Approach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Degenerative Sacroiliitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Degenerative Sacroiliitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 28: World 15-Year Perspective for Degenerative Sacroiliitis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Trauma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Trauma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 31: World 15-Year Perspective for Trauma Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Sacroiliac Joint Dysfunction Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Sacroiliac Joint Dysfunction Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 34: World 15-Year Perspective for Sacroiliac Joint Dysfunction Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 35: USA Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 36: USA Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 37: USA 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 38: USA Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: USA Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 40: USA 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 41: USA Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 43: USA 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 46: USA 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
CANADA
- TABLE 47: Canada Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 49: Canada 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 50: Canada Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 52: Canada 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 55: Canada 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 56: Canada Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Canada Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 58: Canada 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
JAPAN
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 59: Japan Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 61: Japan 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 62: Japan Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 64: Japan 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 65: Japan Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: Japan Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 67: Japan 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 68: Japan Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: Japan Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 70: Japan 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
CHINA
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 71: China Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 73: China 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 74: China Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: China Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 76: China 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 77: China Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: China Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 79: China 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 80: China Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: China Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 82: China 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
EUROPE
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 83: Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for MIS Sacroiliac Joint Fusion by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 85: Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 86: Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: Europe Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 88: Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 89: Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: Europe Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 91: Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 92: Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Europe Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 94: Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 95: Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Europe Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 97: Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
FRANCE
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 98: France Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: France Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 100: France 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 101: France Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: France Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 103: France 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 104: France Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: France Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 106: France 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 107: France Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: France Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 109: France 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
GERMANY
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 110: Germany Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: Germany Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 112: Germany 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 113: Germany Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: Germany Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 115: Germany 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 116: Germany Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: Germany Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 118: Germany 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 119: Germany Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: Germany Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 121: Germany 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
ITALY
- TABLE 122: Italy Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: Italy Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 124: Italy 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 125: Italy Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Italy Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 127: Italy 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 128: Italy Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Italy Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 130: Italy 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 131: Italy Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Italy Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 133: Italy 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
UNITED KINGDOM
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 134: UK Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: UK Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 136: UK 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 137: UK Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: UK Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 139: UK 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 140: UK Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: UK Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 142: UK 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 143: UK Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 144: UK Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 145: UK 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
SPAIN
- TABLE 146: Spain Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Spain Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 148: Spain 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 149: Spain Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Spain Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 151: Spain 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 152: Spain Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 153: Spain Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 154: Spain 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 155: Spain Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Spain Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 157: Spain 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
RUSSIA
- TABLE 158: Russia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Russia Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 160: Russia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 161: Russia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Russia Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 163: Russia 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 164: Russia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: Russia Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 166: Russia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 167: Russia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: Russia Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 169: Russia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
REST OF EUROPE
- TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: Rest of Europe Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 172: Rest of Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: Rest of Europe Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 175: Rest of Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: Rest of Europe Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 178: Rest of Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: Rest of Europe Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 181: Rest of Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
ASIA-PACIFIC
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 183: Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 184: Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 187: Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 190: Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 192: Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 193: Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 196: Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
AUSTRALIA
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 197: Australia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 198: Australia Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 199: Australia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 200: Australia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 201: Australia Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 202: Australia 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 203: Australia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Australia Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 205: Australia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 206: Australia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Australia Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 208: Australia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
INDIA
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 209: India Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: India Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 211: India 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 212: India Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 213: India Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 214: India 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 215: India Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 216: India Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 217: India 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 218: India Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 219: India Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 220: India 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
SOUTH KOREA
- TABLE 221: South Korea Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 222: South Korea Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 223: South Korea 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 224: South Korea Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 225: South Korea Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 226: South Korea 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 227: South Korea Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 228: South Korea Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 229: South Korea 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 230: South Korea Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 231: South Korea Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 232: South Korea 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 234: Rest of Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 235: Rest of Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 237: Rest of Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 238: Rest of Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 241: Rest of Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 243: Rest of Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 244: Rest of Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
LATIN AMERICA
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 245: Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 246: Latin America Historic Review for MIS Sacroiliac Joint Fusion by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 247: Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 248: Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 249: Latin America Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 250: Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 251: Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 252: Latin America Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 253: Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 254: Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 255: Latin America Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 256: Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 257: Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 258: Latin America Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 259: Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
ARGENTINA
- TABLE 260: Argentina Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 261: Argentina Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 262: Argentina 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 263: Argentina Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 264: Argentina Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 265: Argentina 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 266: Argentina Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 267: Argentina Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 268: Argentina 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 269: Argentina Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 270: Argentina Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 271: Argentina 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
BRAZIL
- TABLE 272: Brazil Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 273: Brazil Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 274: Brazil 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 275: Brazil Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 276: Brazil Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 277: Brazil 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 278: Brazil Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 279: Brazil Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 280: Brazil 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 281: Brazil Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 282: Brazil Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 283: Brazil 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
MEXICO
- TABLE 284: Mexico Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 285: Mexico Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 286: Mexico 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 287: Mexico Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 288: Mexico Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 289: Mexico 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 290: Mexico Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 291: Mexico Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 292: Mexico 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 293: Mexico Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 294: Mexico Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 295: Mexico 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 297: Rest of Latin America Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 298: Rest of Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 300: Rest of Latin America Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 301: Rest of Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 303: Rest of Latin America Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 304: Rest of Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 306: Rest of Latin America Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 307: Rest of Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
MIDDLE EAST
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 308: Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 309: Middle East Historic Review for MIS Sacroiliac Joint Fusion by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 310: Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 311: Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 312: Middle East Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 313: Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 314: Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 315: Middle East Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 316: Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 317: Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 318: Middle East Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 319: Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 320: Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 321: Middle East Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 322: Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
IRAN
- TABLE 323: Iran Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 324: Iran Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 325: Iran 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 326: Iran Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 327: Iran Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 328: Iran 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 329: Iran Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 330: Iran Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 331: Iran 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 332: Iran Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 333: Iran Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 334: Iran 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
ISRAEL
- TABLE 335: Israel Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 336: Israel Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 337: Israel 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 338: Israel Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 339: Israel Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 340: Israel 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 341: Israel Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 342: Israel Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 343: Israel 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 344: Israel Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 345: Israel Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 346: Israel 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
SAUDI ARABIA
- TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 348: Saudi Arabia Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 349: Saudi Arabia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 351: Saudi Arabia Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 352: Saudi Arabia 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 354: Saudi Arabia Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 355: Saudi Arabia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 357: Saudi Arabia Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 358: Saudi Arabia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 359: UAE Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 360: UAE Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 361: UAE 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 362: UAE Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 363: UAE Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 364: UAE 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 365: UAE Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 366: UAE Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 367: UAE 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 368: UAE Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 369: UAE Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 370: UAE 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 372: Rest of Middle East Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 373: Rest of Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 375: Rest of Middle East Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 376: Rest of Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 378: Rest of Middle East Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 379: Rest of Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 381: Rest of Middle East Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 382: Rest of Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
AFRICA
- MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 383: Africa Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 384: Africa Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 385: Africa 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
- TABLE 386: Africa Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 387: Africa Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 388: Africa 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
- TABLE 389: Africa Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 390: Africa Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 391: Africa 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
- TABLE 392: Africa Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 393: Africa Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 394: Africa 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030